Core Viewpoint - Meinian Health (002044.SZ) expects a significant increase in revenue and net profit for the first three quarters, driven by AI technology integration and a focus on customer management [1] Financial Performance - Estimated revenue for the first three quarters is between 685 million and 701 million yuan, with a net profit attributable to shareholders ranging from 42 million to 62 million yuan, representing a year-on-year growth of 70.51% to 151.70% [1] - Net profit after excluding non-recurring gains is projected to be between 8.5 million and 22 million yuan, showing a year-on-year increase of 4.35% to 170.09% [1] - Revenue generated from AI technology integration amounts to 249.64 million yuan, reflecting a 71.02% increase compared to the same period last year [1] Business Strategy - The company is actively promoting revenue growth and customer engagement during the peak health check season in the third quarter, maintaining stable overall order signing and customer unit price [1] - There is an increase in the proportion of key customer contracts and check-in shares, with a focus on managing the entire customer journey to enhance conversion, repurchase, and expansion [1] - The company continues to leverage AI and digitalization for efficiency and cost reduction, implementing precise cost-cutting measures while enhancing revenue through differentiated product offerings and exceptional service experiences [1] - The aim is to establish a lean operational system that integrates medical, marketing, and management functions, reinforcing a positive cycle of "professional examination - in-depth service - scientific customization - continuous repurchase" in anticipation of the fourth quarter health check peak [1]